PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
on 10 Feb 2021
Last Applicant/ Owned by
94-96 avenue Ledru Rollin
PARIS
FR
F75011
Serial Number
79126292 filed on 03rd Jan 2013
Registration Number
4561761 registered on 08th Jul 2014
Correspondent Address
Thomas M. Palisi
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
ENTEROME
Human pharmaceutical research; research services provided by a pharmaceutical laboratory, namely, providing medical research testing services in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; Providing medical and scientific research information i Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Human pharmaceutical research; research services provided by a pharmaceutical laboratory, namely, providing medical research testing services in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; Providing medical and scientific research information in the field of metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation, and irritable bowel syndrome; providing medical and scientific research information in the field of pharmaceutical and clinical trials; scientific laboratory services, genetic testing of laboratory animals for pharmaceutical research purposes; biological research in the fields of microbiology and chemistry
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and medicinal products for human and veterinary use, namely, pharmaceutical preparations for treating metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; veterinary products, namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations for treatment of metabolic disorders, immunological disorders, cancers, central nervous systems disorders, gastroenterological disorders, infectious diseases and diarrhea; medicinal products for human and veterinary use, namely, nutritional supplements containing probiotic compositions; sanitary products for use in medicine, namely, sanitary sterilizing preparations, disinfectants for sanitary purposes, sanitary preparations for medical use; dietetic food and substances for medical use in the nature of meal replacement products and prepackaged meal plans, namely, nutritional meal replacement bars adapted for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged entrees for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged snack foods for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged yogurts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome, prepared, prepackaged desserts for medical use for treating metabolic disorders, immunological disorders, central nervous systems disorders, gastroenterological disorders, infectious diseases, diarrhea, constipation and irritable bowel syndrome; nutritional supplements for medical use; food additives for medical use, namely, dietary fiber for treating metabolic disorders, gastroenterological disorders, diarrhea, constipation and irritable bowel syndrome; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, microorganisms and crops
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [003]
Cosmetics and Cleaning Products
[ Cosmetic products, namely, cosmetic creams ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
[ Chemical and biochemical substances used for the manufacture and preservation of foodstuffs, of pharmaceutical, cosmetic and veterinary products, namely, probiotic bacteria and probiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, prebiotic bacteria and prebiotic bacterial cultures for use in the manufacture of food products and pharmaceutical preparations, enzymes for use in the manufacture of food products and pharmaceutical preparations ]
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79126292
Mark Type
No Service Mark
Attorney Docket Number
No REGIM.273
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Dec 2024 | TEAS SECTION 71 RECEIVED |
| 08th Jul 2023 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| 26th Jan 2023 | INTERNATIONAL REGISTRATION RENEWED |
| 12th Dec 2021 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| 04th Nov 2021 | INVALIDATION PROCESSED |
| 04th Nov 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 10th Oct 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 10th Feb 2021 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| 10th Feb 2021 | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 10th Feb 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |